People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AnPac Bio-Medical Science Co., Ltd. | — | Biotechnology | Seed | $4.7M | $23.1M | 2022 |
Aidong Chen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aidong Chen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Edward Tang | 1 | 2 |
| Lin Yu | 1 | 2 |
| Jianhua Shao | 1 | 1 |
| Jinqiu Tang | 1 | 1 |
| Pu Xing | 1 | 1 |
| Chris Chang Yu | 1 | 1 |
| He Yu | 1 | 1 |
| Ren Luo | 1 | 1 |
| Feng Guo | 1 | 1 |
| Sheng Liu | 1 | 1 |
| XueDong Du | 1 | 1 |
| Weidong Dai | 1 | 1 |
| Chang Yu | 1 | 1 |
| Sarah Yu | 1 | 1 |
| Jiefeng Gu | 1 | 1 |
| Yu Chris | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.